[Zhaoyan New Drug: The supply and demand of domestic non-human primate experimental animals are in a tense state] According to reports, Zhaoyan New Drug said at the 2026 semi-annual performance briefing held on September 8 that from the demand side, domestic innovative drug financing and BD licensing transactions will continue to pick up in 2026, bringing about the overall The demand for non-human primate experimental models in the animal industry has increased significantly; from the supply side, the breeding rate of non-human primate experimental animals is relatively stable, the industry's supply elasticity is low, and it is unable to rapidly expand production in line with demand. Therefore, the supply and demand of domestic non-human primate experimental animals are in a tight state, and prices have also increased.